Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

ClinicalTrials.gov ID: NCT01318434

Public ClinicalTrials.gov record NCT01318434. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 5:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) (Triple Reuptake Inhibitor Anti-Depressant Effects - TRIADE Study)

Study identification

NCT ID
NCT01318434
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Euthymics BioScience, Inc.
Industry
Enrollment
342 participants

Conditions and interventions

Interventions

  • EB-1010 25mg BID Drug
  • EB-1010 50mg BID Drug
  • Placebo Drug
  • SSRI Active Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2011
Primary completion
Jan 31, 2013
Completion
Jan 31, 2013
Last update posted
Dec 3, 2015

2011 – 2013

United States locations

U.S. sites
43
U.S. states
21
U.S. cities
42
Facility City State ZIP Site status
Pacific Clinical Research Medical Group Arcadia California 91007
Southwest Research, Inc. Beverly Hills California 90210
Synergy Clinical Research Center National City California 91950
Clinical Innovations, Inc. Santa Ana California 92705
Pacific Clinical Research Medical Group Upland California 91786
Radiant Research, Inc. Denver Colorado 80239
Comprehensive Psychiatric Care Norwich Connecticut 06360
Sanitas Research Coral Gables Florida 33134
Clinical Neuroscience Solution, Inc. Jacksonville Florida 32216
Florida Clinical Research Center Maitland Florida 32751
Clinical Neuroscience Solutions, Inc Orlando Florida 32806
Medical Research Group of Central Florida Sanford Florida 32771
Atlanta Center for Medical Research Atlanta Georgia 30308
AMR Baber Research Naperville Illinois 60563
Psychiatric Medicine Associates Stokie Illinois 60076
Lake Charles Clinical Trials Lake Charles Louisiana 70601
Clinical Insights Glen Burnie Maryland 21061
Cambridge Health Alliance Cambridge Massachusetts 02139
AccelRx Research Fall River Massachusetts 02721
St Charles Psychiatric Associates Saint Charles Missouri 63301
Global Medical Institutes Princeton New Jersey 08540
CRI Worldwide, LLC Willingboro New Jersey 08046
Mount Sinai School of Medicine New York New York 10029
Behavioral Medical Research of Staten Island Staten Island New York 10305
Community Research Cincinnati Ohio 45227
Midwest Clinical Research Center Dayton Ohio 45417
North Star Medical Research Middleburg Heights Ohio 44130
Neurology and Neuroscience Center of Ohio Toledo Ohio 43623
SP Research, PLLC Oklahoma City Oklahoma 73112
Lehigh Valley Hospital Allentown Pennsylvania 18103
Southeastern PA Medical Institute Broomall Pennsylvania 19008
Suburban Research Associates Media Pennsylvania 19063
University of Pennsylvania Philadelphia Pennsylvania 19104
CRI Worldwide Philadelphia Pennsylvania 19139
Scranton Counseling Center Scranton Pennsylvania 18503
Radiant Research Greer South Carolina 29651
Clinical NeuroScience Solutions, Inc. Memphis Tennessee 38119
Vanderbilt University Medical Center Nashville Tennessee 37212
FutureSearch Trials of Dallas Dallas Texas 75231
Radiant Research, Inc. Murray Utah 84123
Aspen Clinical Research Orem Utah 84058
VCU Richmond Virginia 23219
Dean Foundation for Health, Research & Education Middleton Wisconsin 53562

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01318434, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 3, 2015 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01318434 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →